ASXNotification regarding unquoted securities - AVR
other announcement
AVR
Health Care Equipment & Services
Anteris Technologies Global
- Short interest
- 1.97%
- +1.97 pp 30d
- as of 20 Aug 2026
- Reported shorts
- 298.2K
- Shares on issue
- 15.127M
Anteris Technologies Global (AVR) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Notification of cessation of securities - AVR
other announcement
Notification regarding unquoted securities - AVR
other announcement
Entry into a Material Definitive Agreement
other announcement
KalkineWhat Is Behind Anteris Technologies Global Corp (ASX:AVR) ASX Healthcare Stocks Attention?
Highlights Anteris Technologies Global Corp (ASX:AVR) has confirmed a officer arrangement update. The update keeps the stock in focus within Healthcare Stocks. Officer-related disclosures form part of a company's governance transparency, keeping the market informed of changes among its senior personnel arrangements. Anteris Technologies is a medical device company developing heart valve and structural heart technologies. The company has confirmed a officer arrangement update, a development th...
Compensatory Arrangements of Certain Officers
other announcement
Appointment of Chief Financial Officer
other announcement
Google NewsAnteris Technologies Global Corp. (ASX:AVR) Share Price Falls 4.05% as Stock Trades Within Daily Range - Kalkine
Anteris Technologies Global Corp. (ASX:AVR) Share Price Falls 4.05% as Stock Trades Within Daily Range Kalkine
Why Is Anteris Technologies Global (ASX:AVR) Drawing Fresh Attention Among ASX Healthcare Stocks?
Highlights Anteris Technologies Global is in focus after a fresh company disclosure added new context to the public record. The healthcare stocks lens centres on clinical progress, regulatory pathways, commercial execution and funding discipline. The broader Australian market backdrop remains important when reading company-specific developments. Australian shares are being assessed against a shifting mix of company updates, sector conditions and global market signals, making fresh disclosures...
Anteris Technologies Global Corp (ASX: AVR) Share Price Update: Stock Rises After Market Close as Health Care Index Ends Lower - Kalkine
Anteris Technologies Global Corp (ASX: AVR) Share Price Update: Stock Rises After Market Close as Health Care Index Ends Lower Kalkine
Anteris Technologies Global Corp. Secures Federal Court Orders to Address Cleansing Notice Delay
Anteris Technologies Global Corp. (ASX:AVR) has successfully obtained Federal Court of Australia orders to correct an inadvertent administrative error concerning the late submission of a cleansing notice under the Corporations Act 2001 (Cth). The company has requested the lifting of its ASX trading halt effective from market open on 4 August 2026. Key Points On 3 August 2026, the Federal Court of Australia granted relief in proceeding VID862/2026, presided over by Justice Wheatley in Brisbane...
Why Anteris Technologies Is Drawing Attention Despite Cash Burn
Highlights Anteris Technologies maintained a sizeable cash position as it continued advancing cardiovascular device development Investors remained focused on funding durability, clinical progress, and commercial scalability within the medtech sector Structural growth in cardiovascular innovation and minimally invasive therapies continued supporting sector interest Anteris Technologies remained in focus as investors weighed its cash runway, cardiovascular innovation strategy, and long-term pos...
We Think Anteris Technologies Global (ASX:AVR) Can Afford To Drive Business Growth - simplywall.st
We Think Anteris Technologies Global (ASX:AVR) Can Afford To Drive Business Growth simplywall.st
Why Is (ASX:AVR) Advancing Its Heart Valve Study in the US?
Highlights Medicare framework supports clinical trial procedures Global study compares next-gen valve with existing devices Progress expected to strengthen US trial expansion The latest development around (AVR) highlights growing momentum in its global heart valve study, supported by US reimbursement pathways and advancing clinical evaluation. The global spotlight on structural heart innovation has intensified as (ASX:AVR) secures a significant step forward in the United States. The com...